INTERNATIONAL PATENT: BOEHRINGER INGELHEIM INTERNATIONAL GMBH FILES APPLICATION FOR "ANTIBODIES TO CONNECTIVE TISSUE GROWTH FACTOR (CTGF) AND USES THEREOF"

GENEVA, Sept. 8 -- BOEHRINGER INGELHEIM INTERNATIONAL GMBH (Binger Strasse 17355216 INGELHEIM AM RHEIN) filed a patent application (PCT/EP2025/055309) for "ANTIBODIES TO CONNECTIVE TISSUE GROWTH FACTOR (CTGF) AND USES THEREOF" on Feb 27, 2025. With publication no. WO/2025/181215, the details related to the patent application was published on Sep 04, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): BRUNNER, Andreas-David (Boehringer Ingelheim International GmbHGlobal PatentsBinger Strasse 17355216 Ingelheim am Rhein), DITTUS, Lars (Boehringer Ingelheim International GmbHGlobal PatentsBinger St...